Modulation of the Immune Response to Pneumococcal Type 14 Capsular Polysaccharide-protein Conjugates by the Adjuvant Quil A Depends on the Properties of the Conjugates

Overview

Journal Infect Immun

Publisher American Society for Microbiology

Specialty Allergy & Immunology

Date 1989 Apr 1

PMID 2925240

Citations 19

Authors

A F Verheul

A A Versteeg

M J De Reuver

M Jansze

H Snippe

Affiliations

Soon will be listed here.

Abstract

Streptococcus pneumoniae type 14 capsular polysaccharide-bovine serum albumin (S14PS-BSA) conjugates were prepared by water-soluble-carbodiimide-mediated condensation with or without the use of N-hydroxy-sulfosuccinimide. The immunogenicities of the capsular polysaccharide (S14PS) and of the conjugates were studied in (CBA/N x BALB/c)F1 mice and in female BALB/c mice. The response in these mice indicates that S14PS could be classified as a thymus-independent type 2 antigen. Coupling of S14PS to BSA improved the immunogenicity of this polysaccharide, and an immunoglobulin G memory response was evoked. Conjugation with N-hydroxysulfosuccinimide resulted in a product with a higher polysaccharide/protein ratio. This conjugate induced a greater immune response than did the classical conjugate. Quil A enhanced the immune response to S14PS and to most S14PS-BSA conjugates. The enhancement of the immune response to the conjugates seemed to depend on the coupling procedure. Our results indicate that for the construction of immunostimulating complexes based on polysaccharide or oligosaccharide-protein conjugates, attention should be paid to the degree of cross-linking of the antigens involved.

Citing Articles

Sequential Linkage of Carbohydrate Antigens to Mimic Capsular Polysaccharides: Toward Semisynthetic Glycoconjugate Vaccine Candidates against Serotype 14.

Seco B, Xu F, Grafmuller A, Kottari N, Pereira C, Seeberger P ACS Chem Biol. 2020; 15(9):2395-2405.

PMID: 32835479 PMC: 7506939. DOI: 10.1021/acschembio.0c00360.

Identification of the smallest structure capable of evoking opsonophagocytic antibodies against Streptococcus pneumoniae type 14.

Safari D, Dekker H, Joosten J, Michalik D, Carvalho de Souza A, Adamo R Infect Immun. 2008; 76(10):4615-23.

PMID: 18678667 PMC: 2546832. DOI: 10.1128/IAI.00472-08.

Immunogenicity and efficacy of recombinant RSV-F vaccine in a mouse model.

Singh S, Dennis V, Carter C, Pillai S, Jefferson A, Sahi S Vaccine. 2007; 25(33):6211-23.

PMID: 17629376 PMC: 1986827. DOI: 10.1016/j.vaccine.2007.05.068.

Role of complement receptor type 2 and endogenous complement in the humoral immune response to conjugates of complement C3d and pneumococcal serotype 14 capsular polysaccharide.

Mitsuyoshi J, Hu Y, Test S Infect Immun. 2005; 73(11):7311-6.

PMID: 16239528 PMC: 1273882. DOI: 10.1128/IAI.73.11.7311-7316.2005.

Synthetic 6B di-, tri-, and tetrasaccharide-protein conjugates contain pneumococcal type 6A and 6B common and 6B-specific epitopes that elicit protective antibodies in mice.

Jansen W, Hogenboom S, Thijssen M, Kamerling J, Vliegenthart J, Verhoef J Infect Immun. 2001; 69(2):787-93.

PMID: 11159969 PMC: 97953. DOI: 10.1128/IAI.69.2.787-793.2001.

References

Campbell J, PAPPENHEIMER Jr A . Quantitative studies of the specificity of anti-pneumococcal polysaccharide antibodies, types 3 and 8. I. Isolation of oligosaccharides from acid and from enzymatic hydrolysates of S3 and S8. Immunochemistry. 1966; 3(3):195-212. DOI: 10.1016/0019-2791(66)90184-4. View

Lee C . Bacterial capsular polysaccharides--biochemistry, immunity and vaccine. Mol Immunol. 1987; 24(10):1005-19. DOI: 10.1016/0161-5890(87)90067-8. View

Kamerling J, Gerwig G, Vliegenthart J, CLAMP J . Characterization by gas-liquid chromatography-mass spectrometry and proton-magnetic-resonance spectroscopy of pertrimethylsilyl methyl glycosides obtained in the methanolysis of glycoproteins and glycopeptides. Biochem J. 1975; 151(3):491-5. PMC: 1172395. DOI: 10.1042/bj1510491. View

Bradford M . A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248-54. DOI: 10.1016/0003-2697(76)90527-3. View

Leinikki P, Shekarchi I, Dorsett P, Sever J . Enzyme-linked immunosorbent assay determination of specific rubella antibody levels in micrograms of immunoglobulin G per milliliter of serum in clinical samples. J Clin Microbiol. 1978; 8(4):419-23. PMC: 275263. DOI: 10.1128/jcm.8.4.419-423.1978. View

Schneerson R, Barrera O, Sutton A, Robbins J . Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med. 1980; 152(2):361-76. PMC: 2185954. DOI: 10.1084/jem.152.2.361. View

Aplin J, WRISTON Jr J . Preparation, properties, and applications of carbohydrate conjugates of proteins and lipids. CRC Crit Rev Biochem. 1981; 10(4):259-306. DOI: 10.3109/10409238109113601. View

Austrian R . Some observations on the pneumococcus and on the current status of pneumococcal disease and its prevention. Rev Infect Dis. 1981; 3 Suppl:S1-17. DOI: 10.1093/clinids/3.supplement_1.s1. View

Lin K, Lee C . Immune response of neonates to pneumococcal polysaccharide-protein conjugate. Immunology. 1982; 46(2):333-42. PMC: 1555384. View

10.

Svenson S, Lindberg A . Artificial Salmonella vaccines. Prog Allergy. 1983; 33:120-43. DOI: 10.1159/000407424. View

11.

Robbins J, Austrian R, Lee C, Rastogi S, Schiffman G, HENRICHSEN J . Considerations for formulating the second-generation pneumococcal capsular polysaccharide vaccine with emphasis on the cross-reactive types within groups. J Infect Dis. 1983; 148(6):1136-59. DOI: 10.1093/infdis/148.6.1136. View

12.

Zigterman J, van Dam J, Snippe H, Rotteveel F, Jansze M, Willers J . Immunogenic properties of octasaccharide-protein conjugates derived from Klebsiella serotype 11 capsular polysaccharide. Infect Immun. 1985; 47(2):421-8. PMC: 263186. DOI: 10.1128/iai.47.2.421-428.1985. View

13.

Sutton A, Vann W, Karpas A, STEIN K, Schneerson R . An avidin-biotin based ELISA for quantitation of antibody to bacterial polysaccharides. J Immunol Methods. 1985; 82(2):215-24. DOI: 10.1016/0022-1759(85)90353-9. View

14.

Leinonen M, Sakkinen A, Kalliokoski R, Luotonen J, Timonen M, Makela P . Antibody response to 14-valent pneumococcal capsular polysaccharide vaccine in pre-school age children. Pediatr Infect Dis. 1986; 5(1):39-44. DOI: 10.1097/00006454-198601000-00008. View

15.

Austrian R . Polysaccharide vaccines. Ann Inst Pasteur Microbiol (1985). 1985; 136B(3):295-307. DOI: 10.1016/s0769-2609(85)80075-2. View

16.

Schneerson R, Robbins J, Parke Jr J, Bell C, Schlesselman J, Sutton A . Quantitative and qualitative analyses of serum antibodies elicited in adults by Haemophilus influenzae type b and pneumococcus type 6A capsular polysaccharide-tetanus toxoid conjugates. Infect Immun. 1986; 52(2):519-28. PMC: 261031. DOI: 10.1128/iai.52.2.519-528.1986. View

17.

Wicker L, SCHER I . X-linked immune deficiency (xid) of CBA/N mice. Curr Top Microbiol Immunol. 1986; 124:87-101. DOI: 10.1007/978-3-642-70986-9_6. View

18.

Staros J, Wright R, Swingle D . Enhancement by N-hydroxysulfosuccinimide of water-soluble carbodiimide-mediated coupling reactions. Anal Biochem. 1986; 156(1):220-2. DOI: 10.1016/0003-2697(86)90176-4. View

19.

Flebbe L, Braley-Mullen H . Immunopotentiating effects of the adjuvants SGP and Quil A. I. Antibody responses to T-dependent and T-independent antigens. Cell Immunol. 1986; 99(1):119-27. DOI: 10.1016/0008-8749(86)90221-2. View

20.

Flebbe L, Braley-Mullen H . Immunopotentiation by SGP and Quil A. II. Identification of responding cell populations. Cell Immunol. 1986; 99(1):128-39. DOI: 10.1016/0008-8749(86)90222-4. View